Bioreactor calibration and monitoring is a key part of many biological processes, find out how Raman process analyzer aid in ...

Shares of Thermo Fisher Scientific Inc. TMO slid 2.12% to $419.89 Thursday, on what proved to be an all-around great trading ...

Get your weekly dose of the top news that matters in our newsletter.

Following MHRA approval, Stablepharma Ltd has commenced a Phase 1 clinical trial with its lead candidate, fridge-free tetanus and diphtheria vaccine, SPVX02. The Phase 1, first-in-human clinical trial ...

Cultivated meat is an emerging field of food technology, however, to make it viable, it is important to learn how to optimize ...

Argus has trimmed its outlook for Thermo Fisher Scientific, lowering the price target from $620 to $470 while still ...

Uniting RoosterBio's extensive portfolio of hMSC-based products and processes with Thermo Fisher's advanced therapy GMP contract manufacturing capabilities, customers can access a new comprehensive ...

Representative Robert Bresnahan, Jr. decided to spring clean his investment portfolio with gusto on April 8th. He sold off ...

The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

RoosterBio Inc. has partnered with Thermo Fisher Scientific to accelerate the availability of new, potentially life-saving ...

The company is part of a recent trend of pharmaceutical companies tightening their belts. The post Pharma company announces it will lay off 83 Boston-area employees appeared first on Boston.com.